EA1242 (RxFINE-Low)

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
EA1242: A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer with RS<25 (RxFINE-Low)
Principal Investigator
Headshot of Alexandra Thomas
Professor of Medicine
Protocol Number
IRB: PRO00120668
NCT: NCT07391774
Phase
Phase III
ClinicalTrials.gov
Status
OPEN TO ACCRUAL